Evidence map›Paper›PMID 39624070›Full record

ArticleAdvances in pharmacological and pharmaceutical sciences2024

Baicalein Long-Circulating Liposomes Improve Histological and Functional Outcomes After Traumatic Brain Injury.

Dong Yuan, Wenbo Xu, Faisal Raza, Hajra Zafar, Shuangxian Guan, Zhen Wang, Kamran Hidayat Ullah, Hongchao Shi

Abstract read
In one paragraph

Article in Advances in pharmacological and pharmaceutical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dong YuanDepartment of Emergency, JinTan Hospital Affiliated to JiangSu University, 500 Jintan Dadao, Jintan, Changzhou 213200, Jiangsu, China.
Wenbo XuDepartment of Emergency, JinTan Hospital Affiliated to JiangSu University, 500 Jintan Dadao, Jintan, Changzhou 213200, Jiangsu, China.
Faisal RazaSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID https://orcid.org/0000-0001-5569-3535
Hajra ZafarSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID https://orcid.org/0000-0002-0606-5783
Shuangxian GuanDepartment of Emergency, JinTan Hospital Affiliated to JiangSu University, 500 Jintan Dadao, Jintan, Changzhou 213200, Jiangsu, China.
Zhen WangDepartment of Emergency, JinTan Hospital Affiliated to JiangSu University, 500 Jintan Dadao, Jintan, Changzhou 213200, Jiangsu, China.
Kamran Hidayat UllahDepartment of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar, Pakistan.
Hongchao ShiDepartment of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 85 Wujin Road, Shanghai 200080, China.ORCID https://orcid.org/0009-0009-5044-3903

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High mortality and disability have been principally linked with traumatic brain injury (TBI) with this condition being a principal issue in public health. Currently, there is no reliable pharmaceutical agent to salvage the damage caused by TBI. Baicalein (BCL), a traditional Chinese medicine active ingredient, has preliminarily shown repair activity on brain injury. However, BCL has poor water solubility and bioavailability, which culminates in rapid elimination in vivo. Herein, we sought to solve the above-mentioned challenges that are associated with the application of this flavonoid by preparing BCL-loaded long-circulating liposomes (BLC-Lips) via thin-film hydration method. Subsequently, BLC-Lips were applied to TBI model mice to evaluate their effect on brain injury repair. The results showed that the prepared BLC-Lips exhibited smaller sized nanoparticles, excellent polydispersed index (PDI), and zeta (

Indexed as

baicaleinliposomeslong-circulatingtraumatic brain injury

Identifiers

PMID39624070
PMCPMC11611450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.